openPR Logo
Press release

OTC Perspectives Announces 2010 Ad Awards Finalists

03-29-2010 10:39 AM CET | Health & Medicine

Press release from: DTC Perspectives, Inc.

FLORHAM PARK, N.J. [March 22, 2010] – OTC Perspectives, Inc., the leading conference, training and publishing company for over-the-counter (OTC) marketing, today announced the finalists for the 2nd annual OTC National Advertising Awards, presented in conjunction with the OTC National Conference, May 18-19, in Philadelphia, PA. The award winners will be announced at the OTC National Advertising Awards reception, sponsored by HealthCentral, on the night of May l8, at the Penn’s Landing Hyatt in Philadelphia.

Leading healthcare companies and brands will be honored at the awards reception which will showcase the best OTC marketing and advertising campaigns with Gold, Silver, and Bronze awards across eight categories. Brands among the finalist include Vicks, Pepcid, Pepto Bismol, Claritin, Triaminic, Durex, Robitussin, and Zyrtec. For a complete list of award finalists, please visit the 2010 OTC Advertising Awards Website.

"Delegates attending the OTC National Conference will determine the winners for Best Branded TV and Best Branded Print Campaign award," announced Bob Ehrlich, CEO of DTC Perspectives, and OTC National Conference Chairman. "Independent expert judging panels will determine award winners for the other categories."

The OTC National Conference is designed to provide OTC marketers with an opportunity to learn from industry thought leaders and discuss the latest innovations in the industry. Attendees will benefit from case studies, new market research, media & marketing gurus and networking opportunities and this year will include keynote addresses by Jeff Arnold, Founder of Web MD and Chairman of Sharecare; Dr. Jan-Benedict Steenkamp, author of the book “How to Meet the Store Brand Challenge;” and Jim Joseph, President of Lippe Taylor Brand Communications and author of the new book “The Experience Effect.” For conference registration, please visit our Website, www.OTCPerspectives.com or call Debra Sander at (973) 377-2106 ex 221.

OTC Perspectives, Inc. is the leading conference, training and publishing company specializing in the analysis of over-the-counter (OTC) healthcare product marketing. It is our goal to serve as the premier information exchange forum for OTC marketing thought leaders with the publication of OTC Perspectives magazine as well as through attendance at our Conference Series.

OTC Perspectives, Inc. is the leading conference, training and publishing company specializing in the analysis of over-the-counter (OTC) healthcare product marketing. It is our goal to serve as the premier information exchange forum for OTC marketing thought leaders with the publication of OTC Perspectives magazine as well as through attendance at our Conference Series.

30 Columbia Turnpike, Suite 205
Florham Park, NJ 07932
973-377-2106 (Phone)
973-377-1106 (Fax)

General Inquires
Debra Sander
Office Coordinator
(973) 377-2106 x221
Debra@dtcperspectives.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release OTC Perspectives Announces 2010 Ad Awards Finalists here

News-ID: 124992 • Views:

More Releases for OTC

Deadline on Nov. 9th upcoming in Lawsuit for Investors in Harborside Inc. (OTC: …
The Shareholders Foundation announced that a deadline is coming up on November 9, 2020 in the lawsuit filed for certain investors of Harborside Inc. (OTC: HSDEF, OTC: HBORF). Investors who purchased shares of Harborside Inc. (OTC: HSDEF, OTC: HBORF) have certain options and there are strict and short deadlines running. Deadline: November 9, 2020. Harborside Inc. stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to
Investigation for Long-Term Investors in shares of Volkswagen AG (OTC: VWAGY / O …
An investigation on behalf of current long-term investors in shares of Volkswagen AG (OTC: VWAGY / OTC: VLKAF / OTC: VWAPY) was announced over potential breaches of fiduciary duties by certain officers and directors at Volkswagen AG. Investors who purchased shares of Volkswagen AG (OTC: VWAGY / OTC: VLKAF / OTC: VWAPY) and currently hold any of those Volkswagen AG shares have certain options and should contact the Shareholders Foundation at
OTC: VWAGY / OTC: VLKAF / OTC: VWAPY Shareholder Notice: Update in Lawsuit again …
The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in Volkswagen AG (OTC: VWAGY) (OTC: VWAPY) shares. Investors, who purchased shares of Volkswagen AG (OTC: VWAGY) (OTC: VLKAF) (OTC: VWAPY), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. On September 25, 2015, a lawsuit was filed against Volkswagen AG (alleged securities laws violations. The plaintiff claimed that the defendants
OTC Analgesics Market OTC analgesics market is projected to register a steady ex …
About OTC Analgesics Market The global OTC analgesics market is projected to register an above-average CAGR during 2017 to 2022. Global sales of OTC analgesics is estimated to account for nearly US$ 25,000 Mn revenues by 2022-end. Get Sample copy of this Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=75 The trend of using off-label drugs that are affordable and unapproved, but effective in treating diseases, has been witnessing an upsurge over the past few years.
03-14-2018 | Health & Medicine
Fact.MR
OTC Analgesics Market Report 2017-22: Pharmacy to Remain the Most Lucrative OTC …
A fresh study, covering “OTC Analgesics Market Forecast, Trend Analysis & Competition Tracking – Global Review 2017 to 2022” has been broadcasted to wide online repository of Fact MR, which presents deep focus on the healthcare market. This smart study contains precise data that offers a clear insight about market current scenario and future projections for the benefit of readers. Moreover, the study enclosed significant data which tends to make
The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects
ReportsWeb.com has announced the addition of the “Global OTC Drugs Market Research Report 2017” The report focuses on global major leading industry players with information such as company profiles, product picture and specification. GBI Research's latest report, "The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects" discusses trends in the over-the-counter (OTC) pharmaceuticals market and the commercial prospects for switching drugs from prescription-only to OTC status. The report assesses current